An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol

An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol

<strong>Background</strong> Cellular-based therapies represent a platform technology within the rapidly expanding field of regenerative medicine and are distinct from conventional therapeutics—offering a unique approach to managing what were once considered untreatable diseases. Despite...

Full description

Bibliographic Details
Main Authors:	Pettitt, D, Arshaad, Z, Davies, B, Smith, J, French, A, Cole, D, Bure, K, Dopson, S, DiGiusto, D, Karp, J, Reeve, B, Barker, R, Holländer, G, Brindley, D
Format:	Journal article
Published:	BioMed Central 2017

Similar Items

An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol
by: Pettitt, David, et al.
Published: (2017)

Regulatory barriers to the advancement of precision medicine
by: Pettitt, D, et al.
Published: (2016)

Cell therapy commercialization: An assessment of translational barriers
by: Pettitt, D, et al.
Published: (2016)

A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics
by: Smith, J, et al.
Published: (2016)

Insufficiency in the reporting of CAR-T manufacturing protocols - a systematic review and mixed-methods analysis
by: Pettitt, D, et al.
Published: (2018)

Factors affecting the commercialization of cellular based therapeutics
by: Pettitt, D
Published: (2018)

The limitations of QALY: a literature review
by: Pettitt, D, et al.
Published: (2016)

Scalable purification of viral vectors for gene therapy: An appraisal of downstream processing approaches
by: Fuerstenau-Sharp, M, et al.
Published: (2017)

Automation of CAR-T cell adoptive immunotherapy bioprocessing: Technology opportunities to debottleneck manufacturing
by: Bure, K, et al.
Published: (2016)

CAR-T Cells: A systematic review and mixed methods analysis of the clinical trial landscape
by: Pettitt, D, et al.
Published: (2017)

Emerging platform bioprocesses for viral vectors and gene therapies
by: Pettitt, D, et al.
Published: (2016)

Appendix A: Legal framework on the scientific use of animals in research
by: Pettitt, D, et al.
Published: (2017)

Bioprocess decision support tool for scalable manufacture of extracellular vesicles
by: Ng, K, et al.
Published: (2018)

Generating iPSCs: translating cell reprogramming science into scalable and robust biomanufacturing strategies.
by: Silva, M, et al.
Published: (2015)

EU Falsified Medicines Directive mandatory requirements for secondary care: A concise review
by: Naughton, B, et al.
Published: (2016)

Cell assisted lipotransfer in breast augmentation and reconstruction: A systematic review of safety, efficacy, use of patient reported outcomes and study quality
by: Arshad, Z, et al.
Published: (2016)

Cell assisted lipotransfer in breast augmentation and reconstruction: A systematic review of safety, efficacy, use of patient reported outcomes and study quality
by: Smith, J, et al.
Published: (2016)

Patient-controlled analgesia in the pediatric population: morphine versus hydromorphone
by: DiGiusto M, et al.
Published: (2014-08-01)

Cell therapy commercialization
by: Brindley, D, et al.
Published: (2014)

A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies
by: Davies, B, et al.
Published: (2017)

Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study.
by: Davies, B, et al.
Published: (2014)

Effectiveness of medicines authentication technology to detect counterfeit, recalled and expired medicines: a two-stage quantitative secondary care study.
by: Naughton, B, et al.
Published: (2016)

Medicine authentication technology as a counterfeit medicine-detection tool: a Delphi method study to establish expert opinion on manual medicine authentication technology in secondary care
by: Naughton, B, et al.
Published: (2017)

Bioprocess decision support tool for scalable manufacture of extracellular vesicles
by: Ng, KS, et al.
Published: (2022)

Bioprocessing automation in cell therapy manufacturing: Outcomes of special interest group automation workshop
by: Ball, O, et al.
Published: (2018)

Digital health app development standards: a systematic review protocol
by: Van Velthoven, H, et al.
Published: (2018)

Adipose-derived stem cells in aesthetic surgery: a mixed methods evaluation of the current clinical trial, intellectual property, and regulatory landscape
by: Arshad, Z, et al.
Published: (2017)

Establishing good authentication practice (GAP) in secondary care to protect against falsified medicines and improve patient safety
by: Naughton, B, et al.
Published: (2016)

Conditional approval pathways: The 'special' case of global regenerative medicine regulation
by: Smith, J, et al.
Published: (2017)

Establish good genomic practice to guide medicine forward.
by: Barker, K, et al.
Published: (2013)

Sourcing off market commercial real estate acquisition targets
by: Mayo-Smith, James French
Published: (2017)

Therapeutic applications of vitamin D analogues.
by: Reeve, J
Published: (1979)

Products Manufactured From Human Blood and Plasma
by: Ware, J, et al.
Published: (2017)

Protocol for a mixed-methods evaluation of a Massive Open Online Course on real world evidence
by: Meinhert, E, et al.
Published: (2018)

Rational design of a survey protocol for avocado sunblotch viroid in commercial orchards to demonstrate pest freedom.
by: D B Bonnéry, et al.
Published: (2023-01-01)

Rational design of a survey protocol for avocado sunblotch viroid in commercial orchards to demonstrate pest freedom
by: D. B. Bonnéry, et al.
Published: (2023-01-01)

An assessment of implications of adaptive licensing for pharmaceutical intellectual property and regulatory exclusivity rights in the European Union.
by: Meier, A, et al.
Published: (2016)

Bioprocess decision support tool for scalable manufacture of extracellular vesicles
by: Ng, Kelvin S., et al.
Published: (2022)

A multistep research protocol to develop and implement validated guidelines for CMO RFI and RFP processes: biopharmaceutical vendor evaluation and selection minimum standards (BioVesel)
by: Brindley, D, et al.
Published: (2018)

Computer networks and their protocols /
by: Davies, D. W.
Published: (1979)